Tower Research Capital (TRC)’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,847
| Closed | -$7K | – | 7092 |
|
|
2022
Q1 | $7K | Sell |
5,847
-211
| -3% | -$230 | ﹤0.01% | 4832 |
|
|
2021
Q4 | $7K | Buy |
6,058
+156
| +3% | +$232 | ﹤0.01% | 5000 |
|
|
2021
Q3 | $11K | Sell |
5,902
-2,672
| -31% | -$5.25K | ﹤0.01% | 4296 |
|
|
2021
Q2 | $20K | Sell |
8,574
-328
| -4% | -$791 | ﹤0.01% | 3918 |
|
|
2021
Q1 | $24K | Sell |
8,902
-5,991
| -40% | -$17.7K | ﹤0.01% | 3758 |
|
|
2020
Q4 | $36K | Buy |
14,893
+13,389
| +890% | +$30.5K | ﹤0.01% | 3440 |
|
|
2020
Q3 | $3K | Buy |
+1,504
| New | +$3.95K | ﹤0.01% | 4561 |
|
|
2019
Q3 | – | Sell |
-1,065
| Closed | -$4K | – | 4852 |
|
|
2019
Q2 | $4K | Buy |
+1,065
| New | +$5.56K | ﹤0.01% | 3099 |
|
|
2018
Q2 | – | Sell |
-523
| Closed | -$5K | – | 4349 |
|
|
2018
Q1 | $5K | Sell |
523
-93
| -15% | -$772 | ﹤0.01% | 2754 |
|
|
2017
Q4 | $6K | Sell |
616
-446
| -42% | -$4.49K | ﹤0.01% | 2845 |
|
|
2017
Q3 | $12K | Buy |
+1,062
| New | +$40.3K | ﹤0.01% | 3016 |
|
|
2017
Q1 | – | Sell |
-468
| Closed | -$15K | – | 4361 |
|
|
2016
Q4 | $15K | Buy |
468
+254
| +119% | +$8.37K | ﹤0.01% | 2391 |
|
|
2016
Q3 | $9K | Buy |
+214
| New | +$8.39K | ﹤0.01% | 2175 |
|
|
2016
Q1 | – | Sell |
-150
| Closed | -$6K | – | 5356 |
|
|
2015
Q4 | $6K | Sell |
150
-329
| -69% | -$15.7K | ﹤0.01% | 2871 |
|
|
2015
Q3 | $26K | Buy |
+479
| New | +$47.5K | ﹤0.01% | 1529 |
|
|
2015
Q2 | – | Sell |
-278
| Closed | -$26K | – | 5343 |
|
|
2015
Q1 | $26K | Buy |
278
+235
| +547% | +$16.6K | ﹤0.01% | 2052 |
|
|
2014
Q4 | $2K | Sell |
43
-725
| -94% | -$49.5K | ﹤0.01% | 3458 |
|
|
2014
Q3 | $56K | Buy |
+768
| New | +$84.1K | 0.01% | 1443 |
|
|
2014
Q2 | – | Sell |
-84
| Closed | -$12K | – | 4919 |
|
|
2014
Q1 | $12K | Buy |
+84
| New | +$10.3K | ﹤0.01% | 2463 |
|
Other funds holding GNCA
Tower Research Capital (TRC)'s GNCA Position: Q2 2022 in Review
Tower Research Capital (TRC) sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 5,847 shares — an estimated $7K sold.
Tower Research Capital (TRC) first reported a position in GNCA in Q1 2014 and held it in 19 quarters. The position peaked at $56K in Q3 2014. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.
- Tower Research Capital (TRC) reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,847 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $7K.
- Tower Research Capital (TRC) first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Genocea Biosciences, Inc. position peaked at $56K in Q3 2014.
- 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.